Galenica AG
SIX:GALE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Galenica AG
SIX:GALE
|
CH |
|
Oryzon Genomics SA
F:ORN
|
ES |
|
AcuityAds Holdings Inc
TSX:AT
|
CA |
|
C
|
Champion Bear Resources Ltd
XTSX:CBA
|
CA |
|
Pininfarina SpA
MIL:PINF
|
IT |
|
Mathew Easow Research Securities Ltd
BSE:511688
|
IN |
Wall St Price Targets
GALE Price Targets Summary
Galenica AG
According to Wall Street analysts, the average 1-year price target for GALE is 90.27 CHF with a low forecast of 85.85 CHF and a high forecast of 96.6 CHF.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is GALE's stock price target?
Price Target
90.27
CHF
According to Wall Street analysts, the average 1-year price target for GALE is 90.27 CHF with a low forecast of 85.85 CHF and a high forecast of 96.6 CHF.
What is the Revenue forecast for Galenica AG?
Projected CAGR
5%
Over the last 10 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 5 years is 5%.
What is the Gross Profit forecast for Galenica AG?
Projected CAGR
4%
Over the last 10 years, the compound annual growth rate for Gross Profit has been 5%. The projected CAGR for the next 3 years is 4%.
What is the Operating Income forecast for Galenica AG?
Projected CAGR
10%
Over the last 10 years, the compound annual growth rate for Operating Income has been 7%. The projected CAGR for the next 5 years is 10%.
What is the Pre-Tax Income forecast for Galenica AG?
Projected CAGR
8%
Over the last 10 years, the compound annual growth rate for Pre-Tax Income has been 8%. The projected CAGR for the next 3 years is 8%.
What is the Net Income forecast for Galenica AG?
Projected CAGR
9%
Over the last 10 years, the compound annual growth rate for Net Income has been 8%. The projected CAGR for the next 5 years is 9%.
